Cargando…

Exploiting Epigenetic Alterations in Prostate Cancer

Prostate cancer affects an increasing number of men worldwide and is a leading cause of cancer-associated deaths. Beside genetic mutations, many epigenetic alterations including DNA and histone modifications have been identified in clinical prostate tumor samples. They have been linked to aberrant a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baumgart, Simon J., Haendler, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454930/ https://www.ncbi.nlm.nih.gov/pubmed/28486411 http://dx.doi.org/10.3390/ijms18051017

Ejemplares similares

Dysregulated Transcriptional Control in Prostate Cancer
por: Baumgart, Simon J., et al.
Publicado: (2019)

Recent Advances in Prostate Cancer Treatment and Drug Discovery
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2018)

From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2022)

Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
por: Sugawara, Tatsuo, et al.
Publicado: (2019)

Targeting DNA Damage Response in Prostate and Breast Cancer
por: Wengner, Antje M., et al.
Publicado: (2020)

Exploiting epigenetic dependencies in ovarian cancer therapy
por: Coughlan, Aisling Y., et al.
Publicado: (2021)

Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy
por: Kgatle, Mankgopo M., et al.
Publicado: (2016)

Darolutamide antagonizes androgen signaling by blocking enhancer and super‐enhancer activation
por: Baumgart, Simon J., et al.
Publicado: (2020)

Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
por: Raith, Fabio, et al.
Publicado: (2023)

Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer
por: Falahi, Fahimeh, et al.
Publicado: (2014)

Exploiting epigenetics for the treatment of inborn errors of metabolism
por: Rutten, Martijn G. S., et al.
Publicado: (2019)

Comparative Proteomic and Transcriptomic Analysis of the Impact of Androgen Stimulation and Darolutamide Inhibition
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2022)

Epigenetic modulators as therapeutic targets in prostate cancer
por: Graça, Inês, et al.
Publicado: (2016)

Exploiting tumor epigenetics to improve oncolytic virotherapy
por: Forbes, Nicole E., et al.
Publicado: (2013)

Epigenetics in Prostate Cancer
por: Albany, Costantine, et al.
Publicado: (2011)

Epigenetics in a Spectrum of Myeloid Diseases and Its Exploitation for Therapy
por: Maher, Michael, et al.
Publicado: (2021)

Epigenetic regulation of prostate cancer
por: Chin, Suyin P., et al.
Publicado: (2011)

Epigenetic Alterations in Parathyroid Cancers
por: Verdelli, Chiara, et al.
Publicado: (2017)

Exploiting Long Noncoding RNAs as Pharmacological Targets to Modulate Epigenetic Diseases
por: Prabhakar, Bindu, et al.
Publicado: (2017)

Epigenetic regulation of prostate cancer
por: Wang, Ruixin, et al.
Publicado: (2019)

Alterations in the Epigenetic Machinery Associated with Prostate Cancer Health Disparities
por: Craddock, Jenna, et al.
Publicado: (2023)

Epigenetic and Epitranscriptomic Control in Prostate Cancer
por: López, Judith, et al.
Publicado: (2022)

Genetic alterations and epigenetic alterations of cancer-associated fibroblasts
por: Du, Heng, et al.
Publicado: (2017)

Gastric cancer and related epigenetic alterations
por: Patel, Trupti N, et al.
Publicado: (2017)

Epigenetic Alterations in Pancreatic Cancer Metastasis
por: Wang, Sarah S., et al.
Publicado: (2021)

Exploitation of epigenetic variation of crop wild relatives for crop improvement and agrobiodiversity preservation
por: Varotto, Serena, et al.
Publicado: (2022)

Genetic and Epigenetic Alterations in Bladder Cancer
por: Li, Hong-Tao, et al.
Publicado: (2016)

Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer Models
por: Hammer, Stefanie, et al.
Publicado: (2021)

Exploiting ING2 Epigenetic Modulation as a Therapeutic Opportunity for Non-Small Cell Lung Cancer
por: Blondel, Alice, et al.
Publicado: (2019)

Prospects for exploiting epigenetic effects in livestock production
por: Schenkel, Flavio S
Publicado: (2021)

Role of diet in prostate cancer: the epigenetic link
por: Labbé, D P, et al.
Publicado: (2015)

Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention
por: Izzo, Simona, et al.
Publicado: (2020)

Epigenetic mechanisms underlying prostate cancer radioresistance
por: Macedo-Silva, Catarina, et al.
Publicado: (2021)

Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer
por: Pardo, Juan C., et al.
Publicado: (2022)

Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment
por: Zhang, Shouyi, et al.
Publicado: (2023)

The Interactions of microRNA and Epigenetic Modifications in Prostate Cancer
por: Singh, Prashant Kumar, et al.
Publicado: (2013)

Epigenetics of prostate cancer: beyond DNA methylation
por: Schulz, W A, et al.
Publicado: (2006)

Metabolic Signaling to Epigenetic Alterations in Cancer
por: Kim, Jung-Ae, et al.
Publicado: (2018)

Epigenetic Alterations in Human Papillomavirus-Associated Cancers
por: Soto, David, et al.
Publicado: (2017)

Epigenetic Alterations in Inflammatory Bowel Disease and Cancer
por: Yi, Joo Mi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ccdess8o4uv9jv99kmpeagk5rt